Specialty

FDA-cleared AI anesthesiology devices

The FDA's AI-enabled device list has 30 devices whose lead review panel is Anesthesiology, 1.9% of all 1,614 listed devices. They come from 24 companies. The first decision was on March 11, 1997 and the most recent on June 22, 2026.

30AI devices
23Companies
1997First decision
2026-06-22Latest decision

Guides for anesthesiology

Trend: devices per year

1997: 12015: 22017: 12019: 12020: 12022: 22023: 52024: 52025: 82026: 4
1997201520172019202020222023202420252026
FDA-cleared AI anesthesiology devices per year: 1997 1, 2015 2, 2017 1, 2019 1, 2020 1, 2022 2, 2023 5, 2024 5, 2025 8, 2026 4

Most common product codes

All 30 devices, newest first

Frequently asked questions

How many FDA-cleared AI anesthesiology devices are there?

As of the FDA list updated through June 29, 2026, 30 AI-enabled devices have Anesthesiology as their lead review panel (1.9% of the list).

Which companies have the most AI anesthesiology devices?

Huxley Medical (4), Tyto Care , Ltd. (2), Tyto Care Ltd. (2) have the most AI-enabled anesthesiology devices on the FDA list.

Which year had the most AI anesthesiology authorizations?

2025 had the most, with 8 devices.

Which FDA pathways are used for AI anesthesiology devices?

510(k): 26; De Novo: 4.

What was the most recent AI anesthesiology device on the list?

RX-1 Sleep from Vivaquant, Inc. Dba Rhythm Express (K253148), with a decision dated June 22, 2026.